ERBB2 and cancer: The mTOR pathway is a major regulator of autophagy activated downstream of PI3K-Akt, a pathway commonly dysregulated in human cancer (4) and activated by HER2, insulin-like growth factor receptor, and estrogen receptor in breast cancer (5–8), suggesting that it may play an important role in the development of cancer and many other diseases (9).